from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3524/-

LFCtreatmentdescriptionclass of inhibitor

1.519

Amikacinug/mL Amikacintranslation

1.387

Cap5-10ug/mL Capreomycintranslation

1.557

Rox10-50 ug/mL Roxithromycintranslation

0.873

SM2-5 ug/mL Streptomycintranslation

2.009

Tet5-10 ug/mL Tetracyclinetranslation

-0.001

Rif0.2-5ug/mL Rifampicintranscription

0.033

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.595

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.491

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.899

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.150

Clofazimine10-13 ug/mL Clofaziminerespiration

0.241

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.967

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-3.127

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.102

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.439

Econazole10-24 ug/mL Econazole (azole drug)respiration

-1.261

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.517

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.191

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.309

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.794

KCN5-20 ug/mL Potassium cyaniderespiration

0.158

NaN30.2-2 mM Sodium aziderespiration

1.282

Nigericin50 uM Nigericinrespiration

-0.900

TRC10-150 ug/mL Triclosanrespiration

-1.539

TRZ10-25 ug/mL Thioridazinerespiration

0.646

Valinomycin0.5-10 uM Valinomycinrespiration

1.014

ZnSO42 mM ZnSO4respiration

-0.190

menadione6-10 ug/mL Menadionerespiration

0.110

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.574

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.527

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.130

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.502

NRP_1Non-replicating persistence stage 1dosRassociated

0.420

Amp0.2mg/mL AmpicillincellWall

0.531

Cephalexin20-100 ug/mL CephalexincellWall

1.154

Cerulenin0.32-5 ug/mL CerulenincellWall

0.069

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.294

EMB10-20 ug/mL EthambutolcellWall

0.885

Eta12-40 ug/mL EthionamidecellWall

1.420

INH0.2-0.4 ug/mL IsoniazidcellWall

0.227

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.422

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.790

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.242

BZA0.12 mg/mL BenzamidearomaticAmides

0.069

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.102

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.152

H2O24 mM hydrogen peroxideDNAdamaging

0.218

Levo10 ug/mL LevofloxacinDNAdamaging

0.768

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.587

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.119

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.526

UVUV-irradiationDNAdamaging

-1.138

ARP41-4 ug/mL Antitubercular compound ARP4?

0.175

Antimycin12.5-50 ug/mL Antimycin A?

0.333

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.453

PA_110-50 ug/mL Antitubercular compound PA-1?

0.776

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.099

PA8240.2-2 ug/mL PA-824?

0.051

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.021

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.454

Verapamil50 uM Verapamil?

0.411

mercaptoethanol2 mM 2-Mercaptoethanol?

0.257

methoxatin10-20 ug/mL Methoxatin?